AA
Therapeutic Areas
AI Proteins Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TNFR1 Antagonist | Immunology & Inflammation | Discovery |
| Undisclosed Immune Activator | Oncology | Discovery |
| Undisclosed Targeted Radiotherapy | Oncology | Discovery |
| Undisclosed Program 1 (BMS) | Undisclosed | Discovery |
| Undisclosed Program 2 (BMS) | Undisclosed | Discovery |